Top compounds associated with response to CRK


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.098 0.02
mRNA selumetinib:JQ-1 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.093 0.02
mRNA apicidin CTRPv2 pan-cancer AAC -0.084 0.02
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.089 0.02
mRNA Nilotinib CCLE pan-cancer AAC -0.14 0.02
mRNA Irinotecan gCSI pan-cancer AAC 0.15 0.02
mRNA FH535 GDSC1000 pan-cancer AAC 0.091 0.02
mRNA MLN4924 GDSC1000 pan-cancer AAC 0.11 0.03
mRNA EHT 1864 GDSC1000 pan-cancer AAC 0.091 0.03
mRNA AP-24534 GDSC1000 pan-cancer AAC -0.088 0.03
Download CSV